Skip to Content

Sponsored

Asia’s AI Agenda: Survey Demographics and ‘Firmographics’

Survey participants represent a broad cross-section of Asia-based companies and executives.

in partnership withADP

More than 60 Asia-based senior decision makers responded to our 10-question survey. We sought their opinions on advancements in the artificial intelligence (AI) and robotics industries, and we asked how these industries would impact growth prospects for Asian businesses.

Our respondents were senior regional decision makers from more than a dozen industries, with large representation from the final-services, consumer-goods, and retail industries and the professional-services sector. More than half of respondents were CEOs, and another 20 percent were CFOs or other C-suite executives. The majority of our respondents were executives at large multinationals headquartered outside of Asia; roughly equal percentages reported that their head offices were in Europe, North America, or the Asia-Pacific region. More than 70 percent of respondent firms had global annual revenues of more than $1 billion USD, and more than quarter represented companies with turnovers in excess of $10 billion USD annually.

Within the region, most respondents were based in Southeast Asia, where their companies’ regional headquarters were located, with sizable numbers based in Greater China and South Asia as well.

Respondents managed diversified businesses across Asia. One-third reported direct manufacturing presence in the region, roughly equally present across China, Southeast Asia, and South Asia. More than half reported sales, distribution and investment activities in each of those Asian regions.

Next: Infographics on AI

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.